Financial updates
Pharming Reports on Financial Results for the First Half of 2019
Pharming Group N.V. presents its (unaudited) interim financial report for the first half year ended 30 June 2019.
Highlights:
- Delivered 31% increase in revenue, 51% increase in operating profit and 60% increase in net profit year-on-year
- Delivered 21% increase in revenue, with increases in operating profit and net profit compared to Q1 2019
- Increased investment in pipeline to support long-term growth
''We are pleased to report strong results today, demonstrating continued growth in a period of intense competition.''
- Sijmen de Vries - CEO